Clinical Trial Update: Open-Label Extension to Evaluate the Long-Term Safety, Tolerability and Analgesic Efficacy [Phase 3]

View source ↗

Summary

An open-label extension of a Phase 3 trial assessing long-term safety, tolerability, and analgesic efficacy in cancer-related pain, and it has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Low Back Pain

Snippet

Sponsor: Endo Pharmaceuticals | Conditions: Cancers, Pain, Lower Back Pain | Phase 3 | Status: COMPLETED